#424S&P 500 rank

UNP — Union Pacific Corporation

2-yr score: 41.5/100 (Lower 20%)IndustrialsToday
$287.87+0.09%
Description

Union Pacific Corporation, a prominent American railway enterprise, conducts its primary operations through its subsidiary, Union Pacific Railroad Company. The company provides extensive freight transportation services for a wide array of commodities.

Score breakdownLatest quarter49.5 · Fair
Growth
67.7
Quality / Profitability
59.6
Financial health
57.7
Ratio screener
36.0
Track record: 2-yr avg 41.5 (Weak, 8 quarters ≈ 2 yrs) · long-term avg 41.7 (Weak, 40 quarters ≈ 10 yrs) · next earnings Oct 22, 2026 (today)
Valuation context (informational only — not part of the score)
Neutral vs. its own history
Entry timing (informational only — not part of the score)
Neutral
Live market dataPrice updated Oct 21, 4:28 PM ET
P/E (TTM)
23.3
Yield
1.85%
RSI (14)
59.8
vs SMA20
+2.91%
vs SMA50
+0.15%
vs SMA200
+7.44%
Analyst target
$333
+15.7%
10 analysts
AI theoretical price
$274
-4.8%
as of 2026-09-13

Price chart & technical analysis

Loading chart…

AI deep-dive analysisAnalysis as of 2026-09-13 - price/technical figures below reflect that date, not live market data

As of 2026-09-13, Union Pacific trades at $284.40 (market cap ~$169B), a 22.99x trailing P/E and ~21.8x the $13.07 next-FY consensus EPS, after a record Q2 2026 (revenue $6.86B, +11.5% YoY; adjusted EPS $3.41) that beat estimates and triggered target hikes. The stock is up 17.3% over six months and >25% YTD but has cooled 3.18% over the past month with RSI(14) at 35.33, sitting below its 20- and 50-day averages yet 8.74% above its 200-day.

AI sentimentBullish

As of 2026-09-13, sentiment is bullish but decelerating in the tape. The 2026-07-23 Q2 print was a genuine beat (record revenue $6.86B, +12% YoY; adjusted EPS $3.41 vs. a $3.16–$3.41 consensus range; adjusted operating ratio improved 110bp to 59.2%), and sell-side targets moved up sharply after it — Baird $311→$344, Barclays $315→$350, with the consensus mean at $330.50 (range $294–$363, 10 analysts) versus a $284.40 spot price. The 47-rating breakdown is 28 buy/strong-buy vs. 18 hold and 1 sell. Yet the recent tape is soft: -3.18% over one month, -1.8% over one week, RSI 35.33, and price below both the 20-day (~$298) and 50-day (~$295) averages. The bullishness lives in estimates and price targets, not in the last four weeks of price action.

Quarterly trend

Revenue was range-bound at $5.94–6.16B per quarter from Q3 2023 through Q1 2025 and stayed flat at $6.03–6.24B through 2025, then inflected: Q1 2026 $6.217B (+3.2% YoY) and Q2 2026 $6.864B (+11.5% YoY, the best quarter in the 12-quarter data set). That is a real acceleration, but it is one quarter — the late-October Q3 print has to confirm it. Earnings show a level shift, not acceleration: diluted EPS moved from $2.51–2.91 in 2023–24 to $3.01–3.36 in 2025–26, but the recent YoY growth is only ~+6.3% (Q1 2026) and +6.7% (Q2 2026), far below the +11.5% revenue growth. Q2 2026 GAAP operating margin of 40.25% was actually ~67bp below Q2 2025's 40.92%, and net income grew 6.2% while operating income grew 9.7% and revenue 11.5% — i.e., margins have plateaued in a 39–41% GAAP band even as the top line surged. FCF is the standout: Q2 2026 FCF of $2.203B was +58% YoY and the highest in three years (OCF $3.076B), taking TTM FCF to ~$6.51B, and long-term debt fell from $30.29B (Dec 2025) to $29.04B (Jun 2026) while equity rose from $18.47B to $20.67B.

Valuation assessment

Fair-to-full. As of 2026-09-13, the stock trades at 22.99x TTM EPS of $12.35 and ~21.8x the $13.07 next-FY consensus EPS, versus its own 5-year average P/E of 21.39x — roughly a 7% premium to its own history for ~5.8% expected EPS growth, with FMP's PEG at 3.20. P/S is 6.65 vs. a 5-year average of 6.05, P/B is 8.16 (flattered by buyback-shrunk equity), EV/EBITDA is ~14.9x, the FCF yield is ~3.85%, and the dividend yield is 1.85% on the old rate (~2.0% after the 2026-07-29 increase to $1.42/quarter). Nothing here is cheap: investors are paying a quality-franchise multiple for a mid-single-digit grower, and the consensus $330.50 target requires ~25x forward EPS — multiple expansion, not just execution.

Price vs. earnings playbook

As of 2026-09-13, the $330.50 consensus target on $13.07 of next-FY EPS implies ~25.3x earnings, so the Street is underwriting a re-rating on top of the Q2 beat. That only holds if the +11.5% revenue growth seen in Q2 2026 converts into high-single-digit-or-better EPS growth. Right now it isn't: Q2 EPS grew 6.7% while revenue grew 11.5%, and the GAAP operating margin slipped ~67bp YoY. The burden of proof sits on the next two prints. If Q3/Q4 revenue growth decelerates back to 3–5%, a de-rating toward 19–20x produces a $248–$261 stock; a clean beat with genuine margin expansion supports $300+. This is a stock priced for the improvement to continue, with no cushion for a stumble.

Technical picture

As of 2026-09-13, RSI(14) is 35.33 — weak but not yet oversold — with the $284.40 price below the 20-day (~$298, -4.47%) and 50-day (~$295, -3.47%) simple moving averages, but still 8.74% above the 200-day (~$262). Returns: -1.8% one week, -3.18% one month, +4.29% three months, +17.31% six months; the stock sits ~10% below its 52-week high of $315.99 and ~33% above its low of $214.32. Read it as a pullback inside a longer-term uptrend rather than a breakdown. Entry-timing implication: patience pays — RSI under 30 or a test of the ~$262 200-day would improve risk/reward materially, and a close back above ~$295–298 would confirm the pullback is over. Buying mid-pullback at a full multiple is the least attractive version of this trade.

Macro factors
  • Freight demand: carload and intermodal volumes track US industrial production and consumer import activity — Q2 2026's record intermodal quarters show the consumer held up through the spring tariff scare, but a demand rollover would hit volumes and pricing power simultaneously.
  • Interest rates: with cuts anticipated in late 2026, UNP's ~$29.0B of long-term debt becomes cheaper to service and the cost of capital falls, but the company has already been paying debt down aggressively ($1.5B in H1 2026), so the benefit is more about multiple support than a step-change in earnings.
  • Trade policy and cross-border exposure: Mexico traffic via gateways like Ferromex is roughly 10% of revenue, and US Customs and Border Protection's electronic export reporting mandate for loaded rail shipments to Mexico/Canada takes effect 2026-10-26 — a real near-term operational compliance hurdle on a strategically important lane.
  • Regulation: the Surface Transportation Board oversees both rail service standards and the pending Union Pacific–Norfolk Southern merger application, making Washington a larger swing factor than for most industrials.
  • Cost inflation and fuel: labor, fuel, and materials — Q2 2026's revenue surge produced no GAAP operating-margin expansion (40.25% vs. 40.92% a year earlier), which shows cost pressure is real enough to eat a meaningful chunk of incremental revenue.
Key catalysts
  • Q3 2026 earnings (expected late October 2026): the key test of whether Q2's +11.5% revenue growth and the 59.2% adjusted operating ratio are durable or a one-quarter event amplified by easy comparisons and mix.
  • STB review milestones on the Union Pacific–Norfolk Southern transcontinental merger, plus the binding CN memorandum of understanding signed in late July 2026 — approval, denial, or onerous conditions are all live outcomes and a binary driver for the shares.
  • CBP electronic export reporting mandate effective 2026-10-26 for rail freight into Mexico and Canada — a compliance risk that could temporarily disrupt cross-border volumes.
  • Capital return: the 3% dividend increase to $1.42/quarter (payable 2026-09-30), continued buybacks, and the $1.5B of H1 2026 debt paydown that is steadily de-levering the balance sheet (LT debt $30.29B → $29.04B).
  • Late-2026 interest rate cuts, which would lower funding costs and support valuations across capital-intensive, yield-oriented industrials.
Key risks
  • Valuation risk is the biggest one: 22.99x trailing and ~21.8x forward earnings for ~6% EPS growth (PEG 3.20), with the consensus target requiring ~25x forward EPS. A growth disappointment of any kind compresses the multiple fast — 19–20x on $13.07 is $248–$261.
  • Merger regulatory risk: the STB could block the Norfolk Southern combination or impose conditions that erase the strategic rationale, and a long review freezes management attention and capital allocation in the meantime.
  • Cyclical/trade risk: volumes are levered to industrial activity, tariffs, and cross-border trade; renewed tariff escalation or a recession would hit both volume and pricing at a moment when the stock is priced for continued improvement.
  • Financial leverage and liquidity: D/E of 1.508, long-term debt of $29.04B, current ratio of 0.986 and quick ratio of 0.82, against a capex run-rate of roughly $3.6–3.8B/year — perfectly manageable for a railroad, but it removes the option to fund a downturn with the balance sheet.
  • Operating leverage reversal: Q2 2026 revenue rose 11.5% but net income rose only 6.2% and the GAAP operating margin fell 67bp YoY. If cost inflation persists, revenue growth keeps failing to reach the bottom line and the EPS growth needed to justify the multiple never shows up.
Investment thesis

Not a compelling buy at $284.40. This is a wide-moat, well-run franchise — record Q2 2026 revenue of $6.86B, ~40% operating margins, $6.5B of TTM free cash flow, debt and leverage coming down, and a still-credible PSR-driven operating-ratio story — but you are paying 23x trailing and ~21.8x forward earnings for ~6% EPS growth, a 3.2 PEG, 14.9x EV/EBITDA and a 3.85% FCF yield, with my fair-value work landing near $274. The pending Norfolk Southern merger is genuine optionality, but it is unpriced binary regulatory risk rather than a reason to pay up. Existing holders can hold for the operating-ratio improvement and merger catalysts; new money should wait for either confirmation that Q2's revenue acceleration converts into earnings (Q3 print, late October) or a pullback toward the 200-day near $262.

AI theoretical price methodology

Blended as of 2026-09-13: (1) 55% weight on a justified forward P/E of 21.3x — in line with UNP's own 5-year average P/E of 21.39, warranted by record margins and an improving operating ratio but not a re-rating for a ~5.8% EPS grower — applied to the $13.07 next-FY consensus EPS, giving $278; (2) 25% on a FCFE Gordon-growth cross-check ($6.50B TTM FCF grown 3.5% at a 7.5% required return = ~$168B equity, ~$283/share across ~594M diluted shares); (3) 20% on an EV/EBITDA cross-check of 13.5x on ~$13.2B EBITDA less ~$29B net debt, giving ~$253. Weighted result: ~$274, roughly 3.6% below the $284.40 price — i.e., fully valued, and well short of the $330.50 sell-side mean, which requires ~25x forward earnings.

AI lean: NeutralConfidence: Medium
AI review of the deterministic score
Agree

The 49.5 / 'Fair Fundamentals' score is a fair read, though I would nudge it up 5–8 points to the mid-to-high 50s, which keeps it in the same band — hence Agree, not Partially Agree. The fundamentals-only legs (growth 67.7, quality 59.6, financial health 57.7, blending to 63.0) actually understate a wide-moat franchise with a 39.9% operating margin, 38.7% ROE, 11.7% ROIC and a -1.52% accruals ratio (cash earnings running ahead of reported net income, the healthy pattern); the drag comes from the 50%-weighted ratio screener at 36.0, which penalizes P/B of 8.17 and P/S of 6.65 — a valuation and buyback-distorted-equity complaint, not an operating-quality complaint. Two things the backward-looking formula genuinely cannot see cut the other way and keep me from pushing higher: Q2 2026's +11.5% revenue surge came with a GAAP operating margin 67bp below the prior-year quarter and only +6.2% net income, so the margin/quality trend is less exciting than the top line suggests; and the pending UNP–NSC merger is two-sided binary regulatory risk, not free upside. Note also that the 'depressed cyclical near a trough' allowance does not apply here — UNP is at record revenue and near-peak margins, so if anything the formula's risk is peak-ish earnings on a full multiple, not a misunderstood trough. Net: I confirm the score and the band, with a mild upward tilt.

AI-generated analysis for informational purposes only, not financial advice.